These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8165719)

  • 21. Minor but not major histocompatibility antigens of thymus epithelium tolerize precursors of cytolytic T cells.
    von Boehmer H; Hafen K
    Nature; 1986 Apr 17-23; 320(6063):626-8. PubMed ID: 3486368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymic transplantation across an MHC class I barrier in swine.
    Haller GW; Esnaola N; Yamada K; Wu A; Shimizu A; Hansen A; Ferrara VR; Allison KS; Colvin RB; Sykes M; Sachs DH
    J Immunol; 1999 Oct; 163(7):3785-92. PubMed ID: 10490976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of class I major histocompatibility complex antigens on hepatic allograft survival in rats: distribution of donor cells which express class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y; Goto M; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Ogawa M
    Transplant Proc; 1995 Feb; 27(1):540-2. PubMed ID: 7879091
    [No Abstract]   [Full Text] [Related]  

  • 26. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
    Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
    J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of early rejection by soluble MHC class I antigen after allogenic liver transplantation].
    Geissler EK; Scherer MN; Jauch KW; Graeb C
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):641-4. PubMed ID: 14518333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migration of donor cells into the thymus is not essential for induction and maintenance of systemic tolerance after liver transplantation in the rat.
    Kobayashi E; Kamada N; Delriviere L; Lord R; Goto S; Walker NI; Enosawa S; Miyata M
    Immunology; 1995 Feb; 84(2):333-6. PubMed ID: 7751012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttransplant administration of allochimeric major histocompatibility complex class-I-molecules induces true transplantation tolerance.
    Semiltova N; Shen XD; Fishbein MC; Gao F; Slomowitz SJ; Jiao Q; Mukherjee K; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplantation; 2003 Feb; 75(4):550-3. PubMed ID: 12605125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathymic transplantation of donor cells allows a stabilized, incompatible renal transplant to survive indefinitely after cyclosporine withdrawal.
    Perico N; Rossini M; Imberti O; Bontempelli M; Remuzzi G
    Exp Nephrol; 1993; 1(3):185-9. PubMed ID: 8081968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells.
    Oluwole OO; Depaz HA; Gopinathan R; Ali A; Garrovillo M; Jin MX; Hardy MA; Oluwole SF
    Diabetes; 2001 Jul; 50(7):1546-52. PubMed ID: 11423475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides.
    Remuzzi G; Noris M; Benigni A; Imberti O; Sayegh MH; Perico N
    J Exp Med; 1994 Nov; 180(5):1967-72. PubMed ID: 7964472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor-derived soluble MHC antigens plus low-dose cyclosporine induce transplantation unresponsiveness independent of the thymus by down-regulating T cell-mediated alloresponses in a rat transplantation model.
    Behrens D; Lange K; Fried A; Yoo-Ott KA; Richter K; Fändrich F; Krönke M; Zavazava N
    Transplantation; 2001 Dec; 72(12):1974-82. PubMed ID: 11773898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high-responder heart transplant model.
    Geissler EK; Scherer MN; Graeb C
    Transpl Int; 2000; 13 Suppl 1():S452-5. PubMed ID: 11112052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relative contribution of intrathymic inoculation of donor leukocyte subpopulations in the induction of specific tolerance.
    Oluwole SF; Chowdhury NC; Jin MX
    Cell Immunol; 1994 Jan; 153(1):163-70. PubMed ID: 8287488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged survival of rat orthotopic liver allografts after intrathymic inoculation of donor-strain cells.
    Campos L; Alfrey EJ; Posselt AM; Odorico JS; Barker CF; Naji A
    Transplantation; 1993 Apr; 55(4):866-70. PubMed ID: 8475562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymus-mediated immune tolerance to renal allograft is donor but not tissue specific.
    Perico N; Rossini M; Imberti O; Remuzzi G
    J Am Soc Nephrol; 1991 Dec; 2(6):1063-71. PubMed ID: 1777586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responses.
    Geissler EK; Korzun WJ; Graeb C
    Transplantation; 1997 Sep; 64(5):782-6. PubMed ID: 9311723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplant Proc; 1989 Jun; 21(3):3555. PubMed ID: 2662527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.